A
Ability Pharmaceuticals — Seed (estimated) · €700K
Second funding round, closed when the company was still called AB-Therapeutics; it took the name Ability Pharmaceuticals at the same time. Inveready Seed Capital invested €300K. Genoma España put in a €300K soft loan, and existing shareholders, business angels and private investors made up the rest. The first round, in 2010, came from the founders alongside CDTI and ACCIÓ public support.
Lead unknown
RoundSeed (estimated)
Announced21 Sep 2012
CityCerdanyola del Vallès
SectorHealthtech & Bio · Biotech / Oncology
Source
A
